2 Firms Lead Precision BioSciences' $126M IPO

By Abraham Gross
March 28, 2019, 5:34 PM EDT

Cancer-focused biotech Precision BioSciences Inc. began trading Thursday after pricing units Wednesday night in a $126.4 million initial public offering led by Smith Anderson Blount Dorsett Mitchell & Jernigan LLP and...

Already a subscriber? Click here to view full article